Literature DB >> 15722324

Intravitreal triamcinolone acetonide and central serous chorioretinopathy.

J B Jonas, B A Kamppeter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15722324      PMCID： PMC1772575          DOI： 10.1136/bjo.2004.054247

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

1.  Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion.

Authors:  Paul B Greenberg; Adam Martidis; Adam H Rogers; Jay S Duker; Elias Reichel
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

Review 2.  Central serous chorioretinopathy and glucocorticoids.

Authors:  Evrydiki A Bouzas; Panagiotis Karadimas; Constantin J Pournaras
Journal:  Surv Ophthalmol       Date:  2002 Sep-Oct       Impact factor: 6.048

3.  Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema.

Authors:  J B Jonas; A Söfker
Journal:  Am J Ophthalmol       Date:  2001-09       Impact factor: 5.258

4.  Treatment of intraocular proliferations with intravitreal steroids.

Authors:  R Machemer; G Sugita; Y Tano
Journal:  Trans Am Ophthalmol Soc       Date:  1979

5.  Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema.

Authors:  Mandi D Conway; Christina Canakis; Charalampos Livir-Rallatos; Gholam A Peyman
Journal:  J Cataract Refract Surg       Date:  2003-01       Impact factor: 3.351
  5 in total
  10 in total

1.  Association of a Haplotype in the NR3C2 Gene, Encoding the Mineralocorticoid Receptor, With Chronic Central Serous Chorioretinopathy.

Authors:  Elon H C van Dijk; Rosa L Schellevis; Maaike G J M van Bergen; Myrte B Breukink; Lebriz Altay; Paula Scholz; Sascha Fauser; Onno C Meijer; Carel B Hoyng; Anneke I den Hollander; Camiel J F Boon; Eiko K de Jong
Journal:  JAMA Ophthalmol       Date:  2017-05-01       Impact factor: 7.389

2.  Exacerbation of central serous chorioretinopathy following intravitreal triamcinolone injection.

Authors:  M Selim Kocabora; Sahan Durmaz; Nilay Kandemir
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-03       Impact factor: 3.117

3.  [Intravitreal bevacizumab for chronic central serous chorioretinopathy].

Authors:  M F Niegel; N F Schrage; S Christmann; R F Degenring
Journal:  Ophthalmologe       Date:  2008-10       Impact factor: 1.059

4.  Central serous chorioretinopathy in primary hyperaldosteronism.

Authors:  Elon H C van Dijk; Michiel F Nijhoff; Eiko K de Jong; Onno C Meijer; Aiko P J de Vries; Camiel J F Boon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-07-08       Impact factor: 3.117

5.  The association between visual function and retinal structure in chronic central serous chorioretinopathy.

Authors:  Aya Sugiura; Ryosuke Fujino; Nobuko Takemiya; Kimiko Shimizu; Masato Matsuura; Hiroshi Murata; Tatsuya Inoue; Ryo Obata; Ryo Asaoka
Journal:  Sci Rep       Date:  2017-11-24       Impact factor: 4.379

6.  Spectrum of retinal abnormalities in renal transplant patients using chronic low-dose steroids.

Authors:  Elon H C van Dijk; Darius Soonawala; Vera Rooth; Carel B Hoyng; Onno C Meijer; Aiko P J de Vries; Camiel J F Boon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-10-23       Impact factor: 3.117

7.  Exome sequencing in families with chronic central serous chorioretinopathy.

Authors:  Rosa L Schellevis; Elon H C van Dijk; Myrte B Breukink; Jan E E Keunen; Gijs W E Santen; Carel B Hoyng; Eiko K de Jong; Camiel J F Boon; Anneke I den Hollander
Journal:  Mol Genet Genomic Med       Date:  2019-02-06       Impact factor: 2.183

8.  Central serous chorioretinopathy in active endogenous Cushing's syndrome.

Authors:  Joost Brinks; Femke M van Haalen; Thomas J van Rijssen; Nienke R Biermasz; Onno C Meijer; Alberto M Pereira; Camiel J F Boon; Elon H C van Dijk
Journal:  Sci Rep       Date:  2021-02-02       Impact factor: 4.379

9.  Systemic complement activation in central serous chorioretinopathy.

Authors:  Elon H C van Dijk; Roula Tsonaka; Ngaisah Klar-Mohamad; Diana Wouters; Aiko P J de Vries; Eiko K de Jong; Cees van Kooten; Camiel J F Boon
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

Review 10.  Local delivery of corticosteroids in clinical ophthalmology: A review.

Authors:  Adrian T Fung; Tuan Tran; Lyndell L Lim; Chameen Samarawickrama; Jennifer Arnold; Mark Gillies; Caroline Catt; Logan Mitchell; Andrew Symons; Robert Buttery; Lisa Cottee; Krishna Tumuluri; Paul Beaumont
Journal:  Clin Exp Ophthalmol       Date:  2020-01-22       Impact factor: 4.207
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.